生物医学论文如何积累其临床引用:基于PubMed的大规模回顾性分析
How biomedical papers accumulated their clinical citations: A large-scale retrospective analysis based on PubMed
AI总结:
本文基于PubMed超2300万篇论文的大规模回顾性分析,从临床引用水平和转化科学视角揭示了生物医学论文获得临床引用的时间规律,发现高临床引用论文及更接近临床科学的论文在初始和积累阶段均具有显著优势。
摘要:
本文探讨了生物医学论文临床引用的时间特征,包括其获得首次临床引用所需的时间(初始阶段)以及在获得首次临床引用后获得两次或更多临床引用所需的时间(积累阶段)。研究数据使用了PubMed中1940年至2013年间超过2300万篇生物医学论文及其临床引用。我们从临床引用水平和转化科学视角将这些生物医学论文分为三个组和四个类别,并比较不同组或类别生物医学论文的时间特征。从临床引用水平的角度看,结果表明,高临床引用论文在初始阶段和积累阶段均比中等和低临床引用论文具有明显的获得临床引用的优势。同时,随着积累阶段临床引用数量的增加,三组生物医学论文之间获得相应数量临床引用所需时间的差异显著增大。从转化科学的角度看,结果揭示,在初始阶段和积累阶段,更接近临床科学的生物医学论文比更接近基础科学的论文更容易获得临床引用。此外,我们发现高临床引用论文在获得临床引用方面甚至比临床指南或临床试验具有压倒性优势。两个方面的稳健性分析证明了我们结果的可靠性。
英文摘要:
This paper explored the temporal characteristics of clinical citations of biomedical papers, including how long it takes to receive its first clinical citation (the initial stage) and how long it takes to receive two or more clinical citations after its first clinical citation (the build-up stage). Over 23 million biomedical papers in PubMed between 1940 and 2013 and their clinical citations are used as the research data. We divide these biomedical papers into three groups and four categories from clinical citation level and translational science perspectives. We compare the temporal characteristics of biomedical papers of different groups or categories. From the perspective of clinical citation level, the results show that highly clinically cited papers had obvious advantages of receiving clinical citations over medium and lowly clinically cited papers in both the initial and build-up stages. Meanwhile, as the number of clinical citations increased in the build-up stage, the difference in the length of time to receive the corresponding number of clinical citations among the three groups of biomedical papers significantly increased. From the perspective of translational science, the results reveal that biomedical papers closer to clinical science more easily receive clinical citations than papers closer to basic science in both the initial and build-up stages. Moreover, we found that highly clinically cited papers had the desperate advantage of receiving clinical citations over even the clinical guidelines or clinical trials. The robustness analysis of the two aspects demonstrates the reliability of our results.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。